Cargando…
New (55)Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging
Overexpression of folate receptors (FRs) on different tumor types (e.g., ovarian, lung) make FRs attractive in vivo targets for directed diagnostic/therapeutic agents. Currently, no diagnostic agent suitable for positron emission tomography (PET) has been adopted for clinical FR imaging. In this wor...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958329/ https://www.ncbi.nlm.nih.gov/pubmed/31717279 http://dx.doi.org/10.3390/ph12040166 |
_version_ | 1783487388471787520 |
---|---|
author | Radford, Lauren L. Fernandez, Solana Beacham, Rebecca El Sayed, Retta Farkas, Renata Benešová, Martina Müller, Cristina Lapi, Suzanne E. |
author_facet | Radford, Lauren L. Fernandez, Solana Beacham, Rebecca El Sayed, Retta Farkas, Renata Benešová, Martina Müller, Cristina Lapi, Suzanne E. |
author_sort | Radford, Lauren L. |
collection | PubMed |
description | Overexpression of folate receptors (FRs) on different tumor types (e.g., ovarian, lung) make FRs attractive in vivo targets for directed diagnostic/therapeutic agents. Currently, no diagnostic agent suitable for positron emission tomography (PET) has been adopted for clinical FR imaging. In this work, two (55)Co-labeled albumin-binding folate derivatives-[(55)Co]Co-cm10 and [(55)Co]Co-rf42-with characteristics suitable for PET imaging have been developed and evaluated. High radiochemical yields (≥95%) and in vitro stabilities (≥93%) were achieved for both compounds, and cell assays demonstrated FR-mediated uptake. Both (55)Co-labeled folate conjugates demonstrated high tumor uptake of 17% injected activity per gram of tissue (IA/g) at 4 h in biodistribution studies performed in KB tumor-bearing mice. Renal uptake was similar to other albumin-binding folate derivatives, and liver uptake was lower than that of previously reported [(64)Cu]Cu-rf42. Small animal PET/CT images confirmed the biodistribution results and showed the clear delineation of FR-expressing tumors. |
format | Online Article Text |
id | pubmed-6958329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69583292020-01-23 New (55)Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging Radford, Lauren L. Fernandez, Solana Beacham, Rebecca El Sayed, Retta Farkas, Renata Benešová, Martina Müller, Cristina Lapi, Suzanne E. Pharmaceuticals (Basel) Article Overexpression of folate receptors (FRs) on different tumor types (e.g., ovarian, lung) make FRs attractive in vivo targets for directed diagnostic/therapeutic agents. Currently, no diagnostic agent suitable for positron emission tomography (PET) has been adopted for clinical FR imaging. In this work, two (55)Co-labeled albumin-binding folate derivatives-[(55)Co]Co-cm10 and [(55)Co]Co-rf42-with characteristics suitable for PET imaging have been developed and evaluated. High radiochemical yields (≥95%) and in vitro stabilities (≥93%) were achieved for both compounds, and cell assays demonstrated FR-mediated uptake. Both (55)Co-labeled folate conjugates demonstrated high tumor uptake of 17% injected activity per gram of tissue (IA/g) at 4 h in biodistribution studies performed in KB tumor-bearing mice. Renal uptake was similar to other albumin-binding folate derivatives, and liver uptake was lower than that of previously reported [(64)Cu]Cu-rf42. Small animal PET/CT images confirmed the biodistribution results and showed the clear delineation of FR-expressing tumors. MDPI 2019-11-08 /pmc/articles/PMC6958329/ /pubmed/31717279 http://dx.doi.org/10.3390/ph12040166 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Radford, Lauren L. Fernandez, Solana Beacham, Rebecca El Sayed, Retta Farkas, Renata Benešová, Martina Müller, Cristina Lapi, Suzanne E. New (55)Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging |
title | New (55)Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging |
title_full | New (55)Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging |
title_fullStr | New (55)Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging |
title_full_unstemmed | New (55)Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging |
title_short | New (55)Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging |
title_sort | new (55)co-labeled albumin-binding folate derivatives as potential pet agents for folate receptor imaging |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958329/ https://www.ncbi.nlm.nih.gov/pubmed/31717279 http://dx.doi.org/10.3390/ph12040166 |
work_keys_str_mv | AT radfordlaurenl new55colabeledalbuminbindingfolatederivativesaspotentialpetagentsforfolatereceptorimaging AT fernandezsolana new55colabeledalbuminbindingfolatederivativesaspotentialpetagentsforfolatereceptorimaging AT beachamrebecca new55colabeledalbuminbindingfolatederivativesaspotentialpetagentsforfolatereceptorimaging AT elsayedretta new55colabeledalbuminbindingfolatederivativesaspotentialpetagentsforfolatereceptorimaging AT farkasrenata new55colabeledalbuminbindingfolatederivativesaspotentialpetagentsforfolatereceptorimaging AT benesovamartina new55colabeledalbuminbindingfolatederivativesaspotentialpetagentsforfolatereceptorimaging AT mullercristina new55colabeledalbuminbindingfolatederivativesaspotentialpetagentsforfolatereceptorimaging AT lapisuzannee new55colabeledalbuminbindingfolatederivativesaspotentialpetagentsforfolatereceptorimaging |